Seven stocks trade at forward P/Es far above the S&P 500's roughly 22x, leaving little room for disappointment. Tesla, at 186x, needs Robotaxi and Optimus to deliver. SpaceX, at about 108x, is valued near $2T on about $23B of sales. Arm, at 219x, already prices in heavy AI growth. Palantir, at 81x and 66x sales, can't afford slower growth. Intel, at 52x, prices in a foundry turnaround before profits. CrowdStrike, at 172x, and Palo Alto Networks, at 80x, are great businesses at huge premiums. … Show more

Combining estimated NTM revenue growth with trailing GAAP EBITDA margin makes Palo Alto Networks, Datadog, JFrog, Rubrik and Snowflake look overvalued against forward EV/sales. Zoom, Alphabet, Oracle, AppLovin, Microsoft, Fair Isaac, Adobe, Amazon and Teradata remain undervalued on this Rule of 40 comparison; Palantir, Cloudflare and CrowdStrike remain overvalued. x.com 

Analysts' average 12-month targets sit far above current prices, implying massive upside for six stocks. The implied gains are 188% for IREN, 226% for Applied Digital, 100% for Rocket Lab, 113% for Applied Optoelectronics, 125% for CoreWeave and 211% for Ondas. x.com  x.com  x.com  x.com  x.com  x.com 

At $1.5T of margin debt, a market crack could punish stocks vulnerable to cyclical earnings or high expectations. Micron's profits could fall fast if memory prices weaken; SanDisk's earnings could suffer if NAND pricing turns despite booming AI demand. Palantir's sky-high valuation leaves little room for a growth miss, SpaceX's private-market expectations could suffer if sentiment turns, and Tesla's premium could unwind if autonomy and robotics disappoint. x.com  x.com  x.com  x.com  x.com 

Tesla's 200x earnings multiple asks too much of weak current results and speculative future products. Third-quarter revenue fell 0.4% year over year and EBIT missed estimates by 25%, despite gross-margin and cash-flow beats. Robotaxis, humanoids and other future plans may have appeal, but impressive parts of the business do not make the stock worth its current price. x.com  x.com  x.com 

A stronger SpaceX could lift the wider space-stock basket, including AST SpaceMobile, Rocket Lab, Redwire, Planet Labs, Intuitive Machines, Firefly Aerospace and Voyager Technologies. Per DeItaone, JPMorgan raised its SpaceX price target from $240 to $500 while maintaining Overweight. The seven space stocks rose alongside SpaceX after hours. Their initial post-IPO selloff was followed by macro-driven weakness, not further weakness caused by SpaceX. x.com  x.com  x.com 

Rocket Lab still looks ridiculously expensive at 29 times forward sales against SpaceX at 22 times, even after a 65% fall. At 22 times, Rocket Lab would be roughly $38, and SpaceX would still be the pick. SpaceX also has better forward guidance; Rocket Lab's negative adjusted EBITDA makes sales multiples the valuation yardstick. x.com  x.com  x.com  x.com 

Repeated Neutron delays undermine the premium on Rocket Lab stock when execution keeps slipping. The company does not live or die by Neutron, but 50x sales was unjustified; even at 26x 2027 sales, a legitimate price suggests another 50% decline. x.com  x.com 

Rising estimates amid falling growth-stock prices suggest multiple compression rather than a 2021-style fundamental breakdown. Cerebras has nine upward revisions and none downward in 30 days; Bloom raised guidance twice, Nebius is raising GPU prices again, and Lumentum is sold out for 2027. Q3 results and 2027 hyperscaler capex guides in late October to mid-November are the test; weak guides could quickly reverse revisions. x.com 

Stocks trading at 20 times sales or more, including Lumentum, Nebius, AMD, Palantir, AppLovin and Strategy, are at risk going into 2027. Only 13 Nasdaq companies remain at that level, and far more sit in the Russell 2000, where AI high flyers hide among biotech names. x.com